Royal Cornwall Hospitals NHS Trust (RCHT) myeloma patient in remission, thanks to clinical trial

Emma Hunkin has found hope through participating in research at RCHT that has significantly improved her quality of life. The 47-year-old from Penwithick, St Austell, has been living with myeloma, a type of blood cancer, since diagnosis in December 2022.

Emma, who works at a coffee shop, was offered the opportunity to take part in research and join a clinical trial shortly after her diagnosis. The trial, which involves induction chemotherapy, a stem cell transplant, consolidation treatment, and ongoing maintenance treatment, has been a beacon of hope for Emma and her family.

“The support from the Research Team has been incredible,” Emma says. “I feel lucky to have been given the opportunity to be treated through a clinical trial that has put me in a solid remission and keeps me there.”

Emma’s treatment plan includes fortnightly visits to RCHT for infusions and monthly appointments to review her bloods and general health. Despite some side effects that impact her energy levels, Emma continues to work, exercise, and travel, living as well with the treatment as she did before her diagnosis.

Emma’s husband, Neil, and their son, Will, along with their lively puppy, have been a constant source of support to her. The family, who enjoy exploring the Cornish coast path together, is grateful for the invaluable help from the Research Team, especially during the few occasions when Emma has been unwell.

Emma’s story is a testament to the importance and power of research in finding effective treatments for incurable diseases like myeloma. Her journey offers hope and inspiration to others facing similar challenges.